Concepedia

Richard A. Messmann

RA

Statistics

Publications

31

Citations

4.7K

H-Index

24

Active since

2000

Affiliations

Endocyte (United States)(Current)

University of Maryland, Baltimore

National Cancer Institute

Wayne State University

Tulane University

Richard A. Messmann is an author at Endocyte (United States) specializing in pharmacology, medicine, and oncology.

Publications per year

2000–2023

31

Publications

31

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Oliver Sartor, Johann S. de Bono, Kim N. et al. · New England Journal of Medicine · 2021 · 2.6K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

Edward A. Sausville, Susan G. Arbuck, Richard A. Messmann et al. · Journal of Clinical Oncology · 2001 · 294 citations

Medicine, Oncology, Pharmacology +17

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

R. Wendel Naumann, Robert L. Coleman, Robert A. Burger et al. · Journal of Clinical Oncology · 2013 · 233 citations

Medicine, Oncology, Pharmacology +16

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic

Fenil Shah, Derek P. Logsdon, Richard A. Messmann et al. · npj Precision Oncology · 2017 · 157 citations · Full text

Medicine, Cancer Biology, Oncology +15

Exploratory Study of <sup>99m</sup>Tc-EC20 Imaging for Identifying Patients with Folate Receptor–Positive Solid Tumors

Ronald E. Fisher, Barry A. Siegel, Steven L. Edell et al. · Journal of Nuclear Medicine · 2008 · 142 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

1–5 of 31